http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009053804-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04e274f4cfa902968aabdc17ca874420
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5469d8d94de06c9807a6f3a5f524cbf4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
filingDate 2008-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_920f141dc49869fd204e43f705bc93b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0250267ff5189c2b3da09026644d8ea8
publicationDate 2009-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009053804-A3
titleOfInvention Idarubicin for the treatment of lymphoma in a dog
abstract The present invention relates to a method of treating a lymphoma in a dog comprising administering to a dog in need of such treatment a therapeutically effective amount of idarubicin or a pharmaceutically acceptable salt thereof.
priorityDate 2007-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42890
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493376

Total number of triples: 19.